XOFLUZA (baloxavir marboxil)
ANTIVIRAL - INFLUENZA A · INFLUENZA ·+1
GENENTECH
Drug class
Influenza Antiviral Agents - PA Endonuclease Inhibitor
Influenza antiviral agents in the polymerase acidic (PA) endonuclease inhibitor class are targeted antiviral medications designed to impede influenza A and B viral replication. Read more about Influenza Antiviral Agents - PA Endonuclease Inhibitor
2 drugs in this class 2 manufacturers
Drugs in Influenza Antiviral Agents - PA Endonuclease Inhibitor
XOFLUZA (baloxavir marboxil)
ANTIVIRAL - INFLUENZA A · INFLUENZA ·+1
A-S MEDICATION
Filter & compare in the drug finder →
Opens the drug finder with Influenza Antiviral Agents - PA Endonuclease Inhibitor preselected. Add indication or manufacturer filters there.
Influenza antiviral agents in the polymerase acidic (PA) endonuclease inhibitor class are targeted antiviral medications designed to impede influenza A and B viral replication.
They function by inhibiting the endonuclease activity of the viral RNA polymerase PA subunit, thereby blocking the "cap-snatching" process essential for viral messenger RNA transcription.
Clinically, this drug class—exemplified by baloxavir marboxil—is indicated for the treatment of acute, uncomplicated influenza in patients who have been symptomatic for no more than 48 hours, as well as for post-exposure prophylaxis following contact with an infected individual.
-
nih.gov
Influenza antiviral agents in the polymerase acidic (PA) endonuclease inhibitor class are targeted antiviral medications designed to impede influenza A and B viral replication Clinically, this drug class—exemplified by baloxavir marboxil—is indicated for the treatment of acute, uncomplicated influenza in patients who have been symptomatic for no more than 48 hours, as well as for post-exposure prophylaxis following contact with an infected individual
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.